Back to top

Primary Manuscripts

Use of a vaginal Ring containing dapivirine for HIV-1 prevention in women
Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, et al. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med 2016 Dec 1;375(22):2121-32. PMCID:PMC4993693.

Other Key Manuscripts

Accounting for informative sampling in estimation of associations between sexually transmitted infections and hormonal contraceptive methods
Mishra A, Bůžková P, Balkus JE and Brown ER. Accounting for informative sampling in estimation of associations between sexually transmitted infections and hormonal contraceptive methods. Stat Commun Infect Dis 05 Jul 2020 [Epub ahead of print]

Elevated Risk of Bacterial Vaginosis among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study
Peebles K, Kiweewa FM, Palanee-Phillips T, Chappell C, Singh D, Bunge KE, Naidoo L, Makanani B, Jeenarain N, Reynolds D, Hillier SL, Brown ER, Baeten JM, Balkus JE, MTN-020/ASPIRE study team.  Elevated Risk of Bacterial Vaginosis among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study. Clin Infect Dis 2020 Jun 6:ciaa703

Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial
Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET; for the MTN-020/ASPIRE Team. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial. AIDS Behav 2020 May;24(5):1432-1442. PMCID: PMC7162727

Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities
Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T; MTN-020/ASPIRE and MTN-003/VOICE Study Teams. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. AIDS 2020 Mar 15;34(4):559-567. PMCID: PMC7262458

Brief Report: Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention
Peebles K, van der Straten A, Palanee-Phillips T, Reddy K, Hillier SL, Hendrix CW, Harkoo I, Mirembe BG, Jeenarain N, Baeten JM, Brown ER. Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention. J Acquir Immune Defic Syndr 2020 Mar 1;83(3):197-201.  PMCID: PMC7027377

Relationship type and use of the vaginal ring for HIV-1 prevention in the MTN 020/ASPIRE trial
Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET; MTN-020/ASPIRE Study Team. Relationship type and use of the vaginal ring for HIV-1 prevention in the MTN 020/ASPIRE trial. AIDS Behav 2020 Mar;24(3):866-880. PMCID: PMC6864230

Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe
Duby Z, Katz AWK, Browne EN, Mutero P, Etima J, Zimba CC, Woeber K, Atujuna M, Reddy K, van der Straten A; MTN-020/ASPIRE Study Team. Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav 2020 Feb;24(2):617-628. PMCID: PMC6815681

"The state of mind tells me it's dirty": menstrual shame amongst women using a vaginal ring in Sub Saharan Africa
Duby Z, Katz A, Musara P, Nabukeera J, Zimba CC, Woeber K, Palanee-Phillips T, van der Straten A. "The state of mind tells me it's dirty": menstrual shame amongst women using a vaginal ring in Sub Saharan Africa. Women Health 2020 Jan;60(1):72-86.  PMCID: PMC6824969

Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa
Mhlanga FG, Balkus JE, Singh D, Chappell C, Kamira B, Harkoo I, Szydlo D, Mukaka S, Piper J, Hillier SL. Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa. Int Perspect Sex Reprod Health 2019 Dec 17;45:61-69.

Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa
Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T, Tembo T, Etima J, Musara P, Mgodi NM, van der Straten A, MTN-020/ASPIRE Study Team. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Cult Health Sex 2019 Nov;21(11):1209-1224. PMCID: PMC6639142

Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study
Chappell CA, Harkoo I, Szydlo DW, Bunge KE, Singh D, Nakabiito C, Mhlanga F, Kamira B, Piper JM, Balkus JE, Hillier SL; CAT and MTN-020/ASPIRE Study Team. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.  Contraception 2019 Sep;100(3):214-218. PMCID: PMC6699890

Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study
Palanee-Phillips T, Brown ER, Szydlo D, Matovu Kiweewa F, Pather A, Harkoo I, Nair G, Soto-Torres L, Hillier SL, Baeten JM; MTN-020/ASPIRE Study Team. Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study. AIDS 2019 Aug 1;33(10):1619-1622. PMCID: PMC6636847

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring
Riddler SA, Balkus JE, Parikh UM, Mellors JW, Akello C, Dadabhai S, Mhlanga F, Ramjee G, Mayo AJ, Livant E, Heaps AL, O'Rourke C, Baeten JM; MTN-015; MTN-020/ASPIRE Study Teams. Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring. Clin Infect Dis 2019 Jul 18;69(3):523-529. PMCID: PMC6637274

First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring
van der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K, Scheckter R, Soto-Torres L, Palanee-Phillips T, Baeten JM, Mensch B; MTN-020/ASPIRE Study Team. First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr 2019 Jul 1;81(3):304-310. PMCID: PMC6571014

Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial
Sugarman J, Lin L, Baeten JM, Palanee-Phillips T, Brown ER, Matovu Kiweewa F, Mgodi NM, Nair G, Siva S, Seils DM, Weinfurt KP; MTN-020/ASPIRE Study Team.  Preventive Misconception and Risk Behaviors in a Multinational HIV Prevention Trial. AJOB Empir Bioeth 2019 Apr-Jun;10(2):79-87. PMCID: PMC6612263

Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE
Mensch BS, Richardson BA, Husnik M, Brown ER, Kiweewa FM, Mayo AJ, Baeten JM, Palanee-Phillips T, van der Straten A; MTN-020/ASPIRE study team. Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE. AIDS Behav 2019 Feb;23(2):504-512. PMCID: PMC6374159

Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A Prospective Study among High-Risk African Women
Kiweewa FV, Brown E, Mishra A, Nair G, Palanee-Phillips T, Mgodi N, Nakabiito C, Chakhtoura N, Hillier SL, Baeten JM, MTN-020/ASPIRE Study Team. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A Prospective Study among High-Risk African Women. J Int AIDS Soc 2019 Feb;22(2):e25257. PMCID: PMC6393855

Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy
Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y, Moodley J, Kintu K, Reddy K, Kabwigu S, Jeenariain N, Harkoo I, Mgodi N, Piper J, Rees H, Scheckter R, Beigi R, Baeten JM. Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy. J Acquir Immune Defic Syndr 2018 Dec 15;79(5):566-572.

Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial
Palanee-Phillips T, Roberts ST, Reddy K, Govender V, Naidoo L, Siva S, Gafoor Z, Pather A, Matovu F, Hlahla K, Makanani B, Nair G, Schwartz K, Torjesen K, Brown E, Soto-Torres L, Baeten J, Montgomery ET. Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial. J Acquir Immune Defic Syndr 2018 Dec 15;79(5):580-589. PMCID: PMC6231955

Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex
Laborde ND, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M, Naidoo S, Palanee-Phillips T, Baeten JM, Montgomery ET; MTN-020/ASPIRE Study Team. Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex. AIDS Behav 2018 Feb;22(2):437-446.

Performance of a validated risk score to predict HIV-1 acquisition among African women participating in a trial of the dapivirine vaginal ring
Balkus JE, Brown ER, Palanee-Phillips T, Kiweewa FM, Mgodi N, Naidoo L, Mbilizi Y, Jeenarain N, Gaffoor Z, Siva S, Nair G, Pather A, Baeten JM. Performance of a validated risk score to predict HIV-1 acquisition among African women participating in a trial of the dapivirine vaginal ring. J Acquir Immune Defic Syndr 2018 Jan 1;77(1):e8-e10.  PMCID:PMC5720924

Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial
Husnik MJ, Brown ER, Marzinke M, Livant E, Palanee-Phillips T, Hendrix C, Kiweewa FM, Nair G, Soto-Torres LE, Schwartz K, Hillier SL, Baeten JM; MTN-020 ASPIRE Study Team. Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial. J Acquir Immune Defic Syndr 2017 Nov 1;76(3):330-337. PMCID: PMC5634926

Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception
Balkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K, Nair G, Chappell C, Kiweewa FM, Kabwigu S, Naidoo L, Jeenarain N, Marzinke M, Soto-Torres L, Brown ER, Baeten JM. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception. J Acquir Immune Defic Syndr 2017 Oct 1;76(2):e47-e51. PMCID: PMC5597463

Favoring “Peace of Mind”: A Qualitative Study of African Women's HIV Prevention Product Formulation Preferences from the MTN-020/ASPIRE Trial
van der Straten A, Shapley-Quinn M, Reddy K, Cheng H, Etima J, Woeber K, Musara P, Palanee-Phillips T, Baeten JM, Montgomery ET, and on behalf of the MTN-020/ASPIRE Study Team. Favoring “Peace of Mind”: A Qualitative Study of African Women's HIV Prevention Product Formulation Preferences from the MTN-020/ASPIRE Trial. AIDS Patient Care and STDs 2017 July ; 31(7): 305-314 PMCID: PMC5512310

Acceptability and use of a dapivirine vaginal ring in a phase III trial
Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, Baeten JM; MTN-020/ASPIRE Study. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS 2017 May 15;31(8):1159-1167. PMCID: PMC5557083

Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention
Palanee-Phillips T, Schwartz K, Brown ER, Govender V, Mgodi N, et al. Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.  PLoS ONE 2015;10(6): e0128857.

DescriptionDateSize
Publication Policies
ASPIRE Publication Policy (Download) 2018-01-25872.14 KB
Qualitative Concept Mentorship Application (Download) 2016-04-1215.94 KB